glucosamine has been researched along with Disease Exacerbation in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 27 (50.00) | 29.6817 |
| 2010's | 24 (44.44) | 24.3611 |
| 2020's | 3 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Ma, L; Niu, Y; Wang, J; Wang, Z; Xu, X; Yu, Y; Zhang, C | 1 |
| Chen, Y; Dong, X; Du, W; Feng, H; Feng, K; Kang, X; Lei, S; Li, K; Liu, J; Liu, Y; Wang, K; Xia, Y; Yang, M; Yue, H; Zhou, J | 1 |
| Faith, JJ; Fan, TJ; Goeser, L; Hansen, JJ; Lu, K | 1 |
| Abram, F; Delorme, P; Dodin, P; Martel-Pelletier, J; Pelletier, JP; Raynauld, JP | 2 |
| Fernández-Cuadros, ME | 1 |
| Detarya, M; Lebrilla, CB; Park, D; Phoomak, C; Sawanyawisuth, K; Silsirivanit, A; Vaeteewoottacharn, K; Wongkham, C; Wongkham, S | 1 |
| Becerra, E; Deme, P; Doshi, M; Flores-Fernandez, O; Khaled, AR; Nierenberg, DA; Parthasarathy, S | 1 |
| Messina, OD; Vidal Neira, LF; Vidal Wilman, M | 1 |
| Chan, LY; Lai, KN; Leung, JC; Li, RX; Lin, M; Tang, SC; Wong, DW; Wu, HJ; Yiu, WH | 1 |
| Abram, F; Delorme, P; Dorais, M; Hochberg, MC; Martel-Pelletier, J; Pelletier, JP; Raynauld, JP; Roubille, C | 1 |
| Agaliotis, M; Bridgett, L; Day, R; Edmonds, J; Fransen, M; Jan, S; March, L; Nairn, L; Norton, R; Su, S; Votrubec, M; Woodward, M | 1 |
| Ciccotti, MG; Freedman, KB; Gallagher, B; Good, RP; Harwood, MI; Tjoumakaris, FP | 1 |
| Doschak, MR; Fallone, BG; Jaremko, JL; Lambert, RG; Maksymowych, WP; Panahifar, A; Tessier, AG | 1 |
| Eaton, CB; Lapane, KL; McAlindon, TE; Yang, S | 1 |
| Pociask, R | 1 |
| Bruyère, O; Cooper, C; Kovalenko, V; Kucharz, EJ; Reginster, JY; Szántó, S | 1 |
| Bingham, CO; Bradley, JD; Clegg, DO; Dunlop, DD; Finco, MF; Furst, DE; Harris, CL; Jackson, CG; Lane, NE; Lisse, J; Moskowitz, RW; Oddis, CV; Reda, DJ; Sawitzke, AD; Shi, H; Silver, D; Singer, NG; Williams, HJ; Wolfe, F | 1 |
| Bierma-Zeinstra, SM; Garling, EH; Ginai, AZ; Koes, BW; Rozendaal, RM; Uitterlinden, EJ; van Osch, GJ; Verhaar, JA; Weinans, H; Willemsen, SP | 2 |
| Choi, SJ; Ji, JD; Lee, YH; Song, GG; Woo, JH | 1 |
| Black, C; Clar, C; Henderson, R; MacEachern, C; McNamee, P; Quayyum, Z; Royle, P; Thomas, S | 1 |
| Ashtari, F; Janghorbani, M; Savoj, MR; Shaygannejad, V | 1 |
| McKenzie, S; Torkington, A | 1 |
| Pirotta, M | 1 |
| Boudreau, R; Crema, MD; Green, SM; Guermazi, A; Hannon, MJ; Jakicic, JM; Kwoh, CK; Moore, CE; Roemer, FW | 1 |
| Henrotin, YE | 1 |
| Mathew, EM; Nainar, MS; Rajiah, K; Selvan, T | 1 |
| Mena, J; Ojeda-Correal, G; Sherman, AL | 1 |
| Dzielska-Olczak, M; Nowak, JZ | 1 |
| Hojka, V; Jelen, K; Kubový, P; Kůrková, E; Lopot, F; Mensíková, L | 1 |
| Gatterová, J; Giacovelli, G; Machacek, S; Olejarová, M; Pavelká, K; Rovati, LC | 1 |
| Bruyere, O; Ethgen, O; Giacovelli, G; Henrotin, YE; Honore, A; Reginster, JY; Rovati, LC; Seidel, L | 1 |
| Mackler, L; McDiarmid, T; Priebe, D; Tudiver, F | 1 |
| Bruyere, O; Henrotin, Y; Lecart, MP; Reginster, JY | 1 |
| Blakeley, JA; Ribeiro, VE | 1 |
| Abadie, E; Avouac, B; Bouvenot, G; Branco, J; Bruyere, O; Calvo, G; Devogelaer, JP; Dreiser, RL; Ethgen, D; Herrero-Beaumont, G; Kahan, A; Kreutz, G; Laslop, A; Lemmel, EM; Nuki, G; Reginster, JY; Van De Putte, L; Vanhaelst, L | 1 |
| Channark, P; Kittikulsuth, W; Poolsup, N; Suthisisang, C | 1 |
| Kalunian, KC; Wu, CW | 1 |
| Akimoto, K; Kobayashi, T; Nakamura, A; Notoya, K | 1 |
| Lozada, CJ | 1 |
| Wollheim, FA | 1 |
| Martel-Pelletier, J; Pelletier, JP | 1 |
| Bijlsma, JW; Lafeber, FP | 1 |
| Hayashi, K; Ito, M; Kondo, Y; Nakatani, A | 1 |
| Bruyere, O; Dacre, JE; Deroisy, R; Giacovelli, G; Gossett, C; Henrotin, Y; Lee, RL; Lejeune, E; Reginster, JY; Rovati, LC | 1 |
| Buckwalter, JA; Coutts, RD; Dennis, DA; Rosier, RN; Schenck, RC; Stanish, WD | 1 |
| Henrotin, Y; Reginster, JY | 1 |
| Carter, IR | 1 |
| Breedveld, FC; Hazes, JM; Lard, LR; Speyer, I; vander Horst-Bruinsma, IE; Visser, H; Zwinderman, AH | 1 |
| Bruyere, O; Giacovelli, G; Henrotin, YE; Honore, A; Reginster, JY; Rovati, LC; Seidel, L | 1 |
| Lockwood, B; Rapport, L; Sutton, L | 1 |
18 review(s) available for glucosamine and Disease Exacerbation
| Article | Year |
|---|---|
Nutrition, osteoarthritis and cartilage metabolism.
Topics: Cartilage; Chondroitin Sulfates; Disease Progression; Glucosamine; Humans; Nutritional Status; Osteoarthritis; Vitamins | 2019 |
Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Cartilage, Articular; Chondroitin; Dietary Supplements; Disease Progression; Glucosamine; Humans; Hyaluronic Acid; Injections, Intra-Articular; Osteoarthritis, Knee; Randomized Controlled Trials as Topic; Viscosupplements; Vitamins | 2015 |
A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Dietary Supplements; Disease Progression; Glucosamine; Humans; Nonprescription Drugs; Osteoarthritis, Knee; Pain | 2016 |
Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis.
Topics: Chondroitin Sulfates; Clinical Trials as Topic; Data Interpretation, Statistical; Disease Progression; Drug Administration Schedule; Glucosamine; Humans; Knee Joint; Osteoarthritis, Knee; Outcome Assessment, Health Care; Registries; Treatment Outcome | 2010 |
The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation.
Topics: Aged; Chondroitin Sulfates; Cost-Benefit Analysis; Disease Progression; Female; Glucosamine; Humans; Male; Middle Aged; Osteoarthritis, Knee; Randomized Controlled Trials as Topic; United Kingdom | 2009 |
Osteoarthritis - management options in general practice.
Topics: Adrenal Cortex Hormones; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chondroitin; Chronic Disease; Disease Progression; Glucosamine; Humans; Injections, Intra-Articular; Osteoarthritis; Practice Guidelines as Topic; Practice Patterns, Physicians'; Primary Health Care | 2010 |
Arthritis disease - the use of complementary therapies.
Topics: Arthritis, Rheumatoid; Chondroitin; Complementary Therapies; Disease Progression; Fatty Acids, Omega-3; General Practitioners; Glucosamine; Herbal Medicine; Humans; Musculoskeletal Diseases; Nutritional Status; Osteoarthritis; Pain; Pain Management; Soybean Proteins | 2010 |
Use of glucosamine and chondroitin in persons with osteoarthritis.
Topics: Cartilage, Articular; Chondroitin; Complementary Therapies; Dietary Supplements; Disease Progression; Glucosamine; Humans; Osteoarthritis; Osteoarthritis, Knee; Treatment Outcome | 2012 |
[Antiinflammatory therapy in ostheoarthritis including omega 3 and omega 6 fatty acids].
Topics: Acetaminophen; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chondroitin Sulfates; Disease Progression; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Glucosamine; Humans; Osteoarthritis | 2012 |
Clinical inquiries. Do glucosamine or chondroitin cause regeneration of cartilage in osteoarthritis?
Topics: Cartilage, Articular; Chondroitin Sulfates; Disease Progression; Evidence-Based Medicine; Glucosamine; Humans; Osteoarthritis; Randomized Controlled Trials as Topic; Regeneration; Treatment Outcome | 2003 |
Naturocetic (glucosamine and chondroitin sulfate) compounds as structure-modifying drugs in the treatment of osteoarthritis.
Topics: Antirheumatic Agents; Chondroitin Sulfates; Disease Progression; Glucosamine; Humans; Osteoarthritis | 2003 |
Glucosamine and osteoarthritis.
Topics: Activities of Daily Living; Disease Progression; Evidence-Based Medicine; Glucosamine; Humans; Lobbying; Nurse's Role; Nursing Assessment; Osteoarthritis; Patient Education as Topic; Quality of Life; Range of Motion, Articular; Self Care; Treatment Outcome | 2004 |
Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.
Topics: Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cartilage, Articular; Disease Progression; Glucosamine; Humans; Interleukin-1; Joints; Magnetic Resonance Imaging; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Practice Guidelines as Topic; Radiography; Treatment Outcome | 2004 |
Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials.
Topics: Disease Progression; Glucosamine; Humans; Osteoarthritis, Knee; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2005 |
New developments in osteoarthritis.
Topics: Acetaminophen; Acupuncture Therapy; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Chondroitin; Colchicine; Disease Progression; Glucosamine; Gout Suppressants; Humans; Osteoarthritis; Radiography; Synovial Membrane | 2005 |
Glucosamine in osteoarthritis: questions remain.
Topics: Chondroitin; Disease Progression; Evidence-Based Medicine; Glucosamine; Humans; Osteoarthritis; Treatment Outcome | 2007 |
DMOAD developments: present and future.
Topics: Acetates; Anthraquinones; Antirheumatic Agents; Chondroitin; Clinical Trials as Topic; Diphosphonates; Disease Progression; Doxycycline; Glucosamine; Humans; Hyaluronic Acid; Matrix Metalloproteinase Inhibitors; Osteoarthritis; Pyrroles; Risk Factors | 2007 |
The increasing need for nonoperative treatment of patients with osteoarthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chondroitin Sulfates; Disease Progression; Exercise; Glucosamine; Humans; Hyaluronic Acid; Orthotic Devices; Osteoarthritis; Osteoarthritis, Knee | 2001 |
14 trial(s) available for glucosamine and Disease Exacerbation
| Article | Year |
|---|---|
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens.
Topics: Aged; Chondroitin Sulfates; Dietary Supplements; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glucosamine; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Radiography; Treatment Outcome | 2015 |
The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial.
Topics: Aged; Cartilage, Articular; Chondroitin Sulfates; Dietary Supplements; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glucosamine; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Radiography; Treatment Outcome | 2008 |
Effect of glucosamine sulphate on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial.
Topics: Aged; Dietary Supplements; Disease Progression; Double-Blind Method; Female; Glucosamine; Hip Joint; Humans; Male; Middle Aged; Osteoarthritis, Hip; Pain Measurement; Radiography; Severity of Illness Index; Treatment Outcome | 2009 |
Effects of adjunct glucosamine sulfate on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized, placebo-controlled trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Glucosamine; Humans; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Severity of Illness Index; Young Adult | 2010 |
Risk factors for magnetic resonance imaging-detected patellofemoral and tibiofemoral cartilage loss during a six-month period: the joints on glucosamine study.
Topics: Adult; Aged; Cartilage, Articular; Chronic Pain; Disease Progression; Female; Glucosamine; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Middle Aged; Osteoarthritis, Knee; Risk Adjustment; Treatment Outcome | 2012 |
A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Drug Therapy, Combination; Female; Glucosamine; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2012 |
Influence of SYSADOA group chemicals on progression of human knee joint osteoarthritis: new objective evaluation method - measuring of rheological properties in vivo.
Topics: Aged; Biomechanical Phenomena; Chondroitin Sulfates; Disease Progression; Female; Glucosamine; Humans; Hyaluronic Acid; Knee Joint; Male; Middle Aged; Models, Biological; Osteoarthritis, Knee; Rheology; Treatment Outcome; Viscosupplements | 2012 |
Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.
Topics: Administration, Oral; Aged; Dietary Supplements; Disease Progression; Double-Blind Method; Female; Glucosamine; Humans; Knee Joint; Longitudinal Studies; Male; Middle Aged; Osteoarthritis, Knee; Pain; Treatment Outcome | 2002 |
Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate.
Topics: Aged; Disease Progression; Double-Blind Method; Female; Glucosamine; Humans; Male; Osteoarthritis, Knee; Prognosis; Prospective Studies; Radiography | 2003 |
Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial.
Topics: Administration, Oral; Aged; Arthroplasty, Replacement, Hip; Disease Progression; Double-Blind Method; Glucosamine; Hip Joint; Humans; Middle Aged; Osteoarthritis, Hip; Pain; Sensitivity and Specificity | 2008 |
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.
Topics: Administration, Oral; Aged; Dietary Supplements; Disease Progression; Double-Blind Method; Female; Glucosamine; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Placebos; Radiography; Statistics, Nonparametric; Treatment Outcome | 2001 |
Does glucosamine sulfate affect progression of symptoms and joint structure changes in osteoarthritis?
Topics: Disease Progression; Glucosamine; Humans; Knee; Middle Aged; Osteoarthritis; Severity of Illness Index; Treatment Outcome | 2001 |
Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies.
Topics: Activities of Daily Living; Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Chloroquine; Cohort Studies; Disease Progression; Drug Combinations; Female; Foot; Glucosamine; Hand; Health Status; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Radiography; Sulfasalazine; Time Factors | 2001 |
Radiologic features poorly predict clinical outcomes in knee osteoarthritis.
Topics: Aged; Arthrography; Disability Evaluation; Disease Progression; Double-Blind Method; Glucosamine; Humans; Knee Joint; Osteoarthritis, Knee; Pain Measurement; Reproducibility of Results; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2002 |
22 other study(ies) available for glucosamine and Disease Exacerbation
| Article | Year |
|---|---|
Corosolic acid inhibits cancer progression by decreasing the level of CDK19-mediated O-GlcNAcylation in liver cancer cells.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinases; Disease Progression; Gene Expression Regulation, Neoplastic; Glucosamine; Glucose; Glycosylation; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; RNA, Messenger; Triterpenes; YAP-Signaling Proteins | 2021 |
The Identified Hub Gene GlcN in Osteoarthritis Progression and Treatment.
Topics: Cell Line; Computational Biology; Databases, Genetic; Disease Progression; Gene Ontology; Genetic Markers; Glucosamine; Humans; Osteoarthritis; Protein Interaction Maps; Signal Transduction; Transcriptome | 2021 |
Enterococcus faecalis Glucosamine Metabolism Exacerbates Experimental Colitis.
Topics: Animals; Biomarkers; Colitis; Disease Models, Animal; Disease Progression; Disease Susceptibility; Dysbiosis; Enterococcus faecalis; Gastrointestinal Microbiome; Gene Expression Regulation, Bacterial; Glucosamine; Host Microbial Interactions; Inflammatory Bowel Diseases; Metagenome; Metagenomics; Mice; Mice, Knockout | 2021 |
Reply.
Topics: Chondroitin Sulfates; Disease Progression; Glucosamine; Humans; Osteoarthritis, Knee | 2018 |
Does glucosamine/chondroitin sulfate have a long-term effect on the progression of structural changes in knee osteoarthritis? Comment on the article by Raynauld et al.
Topics: Chondroitin Sulfates; Diagnostic Tests, Routine; Disease Progression; Glucosamine; Humans; Osteoarthritis, Knee | 2018 |
O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Proliferation; Cholangiocarcinoma; Disease Progression; Female; Glucosamine; Glycosylation; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Metastasis; Protein Transport; Treatment Outcome | 2019 |
Cypate and Cypate-Glucosamine as Near-Infrared Fluorescent Probes for In Vivo Tumor Imaging.
Topics: A549 Cells; Animals; Cell Line, Tumor; Disease Progression; Fluorescent Dyes; Glucosamine; Glucose; Hep G2 Cells; Humans; Indoles; Metabolic Networks and Pathways; Mice; Mice, Nude; Neoplasms; Pilot Projects; Propionates; Spectroscopy, Near-Infrared; Tissue Distribution | 2019 |
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
Topics: Albuminuria; Animals; Blood Glucose; Blood Urea Nitrogen; Chemokine CCL2; Chemokine CCL5; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Glucosamine; HMGB1 Protein; Kidney; Macrophages; Mice; Mice, Knockout; NF-kappa B; Nitric Oxide Synthase Type III; Osteopontin; Streptozocin; Time Factors; Toll-Like Receptor 4; Transforming Growth Factor beta | 2013 |
First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort.
Topics: Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Chondroitin Sulfates; Disease Progression; Female; Glucosamine; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Osteoarthritis, Knee; Pain Measurement; Radiography; Treatment Outcome | 2015 |
Development and reliability of a multi-modality scoring system for evaluation of disease progression in pre-clinical models of osteoarthritis: celecoxib may possess disease-modifying properties.
Topics: Animals; Anterior Cruciate Ligament; Bone Cysts; Bone Marrow Diseases; Cartilage, Articular; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Disease Progression; Glucosamine; Knee Injuries; Magnetic Resonance Imaging; Osteoarthritis, Knee; Osteophyte; Pyrazoles; Rats; Reproducibility of Results; Severity of Illness Index; Sulfonamides; Synovitis; X-Ray Microtomography | 2014 |
Effects of glucosamine and chondroitin supplementation on knee osteoarthritis: an analysis with marginal structural models.
Topics: Aged; Chondroitin; Dietary Supplements; Disease Progression; Drug Combinations; Female; Follow-Up Studies; Glucosamine; Humans; Knee; Male; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Treatment Outcome | 2015 |
OTC treatment for osteoarthritis. Can over-the-counter joint pain supplements delay the progression of OA?.
Topics: Anti-Inflammatory Agents; Dietary Supplements; Disease Progression; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Glucosamine; Humans; Nonprescription Drugs; Osteoarthritis | 2011 |
Long-Term Effects of Glucosamine and Chondroitin Sulfate on the Progression of Structural Changes in Knee Osteoarthritis: Six-Year Followup Data From the Osteoarthritis Initiative.
Topics: Aged; Cartilage, Articular; Chondroitin Sulfates; Disease Progression; Female; Follow-Up Studies; Glucosamine; Humans; Knee; Male; Middle Aged; Osteoarthritis, Knee; Time; Treatment Outcome | 2016 |
Interpretation of metaanalyses: pitfalls should be more widely recognized.
Topics: Antirheumatic Agents; Chondroitin; Data Interpretation, Statistical; Disease Progression; Glucosamine; Humans; Meta-Analysis as Topic; Osteoarthritis; Outcome Assessment, Health Care; Radiography | 2012 |
Fursultiamine, a vitamin B1 derivative, enhances chondroprotective effects of glucosamine hydrochloride and chondroitin sulfate in rabbit experimental osteoarthritis.
Topics: Animals; Body Weight; Cartilage; Chondroitin Sulfates; Disease Models, Animal; Disease Progression; Fursultiamin; Glucosamine; Immunohistochemistry; Male; Matrix Metalloproteinase 1; Osteoarthritis; Protective Agents; Rabbits; Tibia | 2005 |
Prescription of glucosamine for osteoarthritis: does it work and is it safe?
Topics: Antirheumatic Agents; Disease Progression; Glucosamine; Humans; Osteoarthritis; Placebo Effect; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
Summaries for patients. Glucosamine sulfate to treat hip osteoarthritis.
Topics: Administration, Oral; Aged; Arthroplasty, Replacement, Hip; Disease Progression; Double-Blind Method; Glucosamine; Hip Joint; Humans; Middle Aged; Osteoarthritis, Hip; Pain; Sensitivity and Specificity | 2008 |
Glucosamine sulfate in osteoarthritis: the jury is still out.
Topics: Disease Progression; Glucosamine; Humans; Osteoarthritis, Hip; Pain | 2008 |
Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice.
Topics: Administration, Oral; Animals; Blood Glucose; Chitin; Chitosan; Diabetes Mellitus, Experimental; Disease Progression; Dose-Response Relationship, Drug; Glucosamine; Lactic Acid; Male; Mice; Mice, Inbred ICR; Molecular Weight; Substance Withdrawal Syndrome | 2000 |
More good news on glucosamine.
Topics: Disease Progression; Glucosamine; Humans; Osteoarthritis | 2001 |
[Pharmacy clinics. How I treat...Osteoarthritis. 2nd part: new therapeutic perspectives].
Topics: Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Chondroitin; Disease Progression; Glucosamine; Humans; Hyaluronic Acid; Osteoarthritis | 2001 |
Glucosamine: con or cure?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Glucosamine; Humans; Osteoarthritis | 2002 |